Contact
Please use this form to send email to PR contact of this press release:
Surveyed Top 50 Pharma and Biotech Companies Report Average Per-Patient Costs of $57,500 During Non-Adaptive Phase 1 Studies
TO:
Please use this form to send email to PR contact of this press release:
Surveyed Top 50 Pharma and Biotech Companies Report Average Per-Patient Costs of $57,500 During Non-Adaptive Phase 1 Studies
TO: